Product Information

LOTEPREDNOL ETABONATE 0.5% DRP is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $17.3853 per ML under NDC 62756023255. Its NADAC has been published 287 times since May 26, 2021.

FDA first approved this application on Feb 26, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LOTEPREDNOL ETABONATE 0.5% DRP

Loteprednol Etabonate
$17.3853per ML

Strength

5 mg/mL

NDC

62756023255

Classification

Generic

Dosage Form

SUSPENSION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

LOTEPREDNOL ETABONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA212450

FDA Approved

2/26/2021

TE Code

AB

On Market Since

5/1/2021

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for LOTEPREDNOL ETABONATE 0.5% DRP has been published 287 times since May 26, 2021, and over the history we have for it it has declined 55.8%. The table below summarizes its recorded NADAC range and movement.

Current price$17.3853 per ML
All-time high$40.1410 (Jul 14, 2021)
All-time low$8.9795 (Apr 23, 2025)
52-week high$22.0153
52-week low$17.3853
Median price$23.5454
Average price$25.6165
Largest weekly change-33.1% (Dec 20, 2023)
Weeks tracked287
Tracking sinceMay 26, 2021

Price History

1W

-7.1%

1M

-18.0%

3M

-20.3%

6M

-14.0%

1Y

-16.1%

3Y

-32.4%

5Y

-44.7%

All

-55.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LOTEPREDNOL ETABONATE 0.5% DRP?

The current National Average Drug Acquisition Cost (NADAC) for LOTEPREDNOL ETABONATE 0.5% DRP, manufactured by Sun Pharmaceutical Industries Inc., is $17.3853 per ML (NDC 62756023255), effective Nov 18, 2026.

How has the price of LOTEPREDNOL ETABONATE 0.5% DRP changed over time?

Over the history we have for it, the NADAC for LOTEPREDNOL ETABONATE 0.5% DRP has declined 55.8%. It has been tracked across 287 weekly CMS publications since May 26, 2021.

What are the highest and lowest recorded NADAC prices for LOTEPREDNOL ETABONATE 0.5% DRP?

Since May 26, 2021, the NADAC for LOTEPREDNOL ETABONATE 0.5% DRP has ranged from a low of $8.9795 (Apr 23, 2025) to a high of $40.1410 (Jul 14, 2021), with a median of $23.5454 per ML.

Are there cheaper alternatives to LOTEPREDNOL ETABONATE 0.5% DRP?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOTEPREDNOL ETABONATE 0.5% DRP, is $9.8751 per ML — about 43% below LOTEPREDNOL ETABONATE 0.5% DRP.

Who manufactures LOTEPREDNOL ETABONATE 0.5% DRP?

LOTEPREDNOL ETABONATE 0.5% DRP (NDC 62756023255) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.